Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Medical and Regulatory Affairs State of the Nation: Cannabis-Based Therapies By Premier Research August 2, 2018 Global Compliance Why and How Global Healthcare Product Regulators are Joining Forces By Premier Research July 31, 2018 Patient and Stakeholder Engagement The Art and Science of Selecting Patients for Phase 1 Oncology Studies By Premier Research July 17, 2018 Clinical ResearchPhase 1 - Phase 4 Key Considerations When Designing a Phase 1 Oncology Trial By Premier Research July 10, 2018 Data Management & Biostatistics Demystifying the Differences Between DMCs and CECs By Livia Hlavackova July 5, 2018 Study Design Considerations for the Design and Execution of Medical Device Trials By Premier Research July 3, 2018 Previous 1 …30 31 32 33 34 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today